Perspectives by the Leerink Center for Pharmacoeconomics
Episodes
What’s Behind Drug Pricing: The Hidden Role and Limits of Cost-Effectiveness Analysis
31 Mar 2026
Contributed by Lukas
In this episode of Perspectives by the Leerink Center for Pharmacoeconomics, Melanie Whittington breaks down a fundamental—and increasingly conseque...
Making Value Propositions Clearer with Peter Kolchinsky, PhD, Founder and Managing Partner, RA Capital Management
02 Mar 2026
Contributed by Lukas
Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, talks with Peter Kolchinsky, PhD, Founder and Managing Partner of RA Capit...
Specialty Drug Coverage Predictions with James Chambers, PhD, MPharm, Professor of Medicine, CEVR, Tufts Medical Center
02 Feb 2026
Contributed by Lukas
Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, interviews James Chambers, PhD, MPharm, Professor of Medicine in the Cente...
The National Pharmaceutical Council President and CEO & Former Trump Drug Pricing Advisor, John O'Brien, PharmD, MPH
08 Jan 2026
Contributed by Lukas
Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, talks with John M. O'Brien, PharmD, MPH, President and CEO of the National...
David Hong, MD, Steve Potts, PhD, MBA, and Vivek Subbiah, MD talk Pan-Tumor Approvals in a Post-IRA World
02 Dec 2025
Contributed by Lukas
Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, talks with Vivek Subbiah, MD, David Hong, MD, and Steve Potts, PhD, MBA to disc...
Head of the Leerink Center for Pharmacoeconomics, Melanie Whittington, PhD
03 Nov 2025
Contributed by Lukas
Diane Vieira, Head of Marketing & Communications at Leerink Partners, interviews Melanie Whittington, PhD, Head of the Leerink Center of Pharmacoecono...
Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech
06 Oct 2025
Contributed by Lukas
Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech, t...
The IP Policy Institute’s Joshua Kresh and Emily Michiko Morris
08 Sep 2025
Contributed by Lukas
Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Joshua Kresh and Emily Michiko Morris from The IP Policy Institute a...
Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA
13 Aug 2025
Contributed by Lukas
Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, interviews Ulrich Neumann, MBA, MSc, MA, Director of Access and Policy Res...
Head of Patient Engagement and Patient-Centered Innovation, Raven, RA Capital's healthcare incubator, Gunnar Esiason, MBA, MPH
14 Jul 2025
Contributed by Lukas
Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, talks with Gunnar Esiason, Head of Patient Engagement and Patient-Centered Inno...
Vice Chair of Research and Associate Professor, University of Utah, Joey Mattingly, PharmD, MBA, PhD
17 Jun 2025
Contributed by Lukas
Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, interviews Joey Mattingly, PharmD, MBA, PhD, Vice Chair of Research and As...
Chief Science Officer, National Pharmaceutical Council, Jon Campbell, PhD
21 May 2025
Contributed by Lukas
Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Jon Campbell, Chief Science Officer of the National Pharmaceutical C...
Head of U.S. Public Affairs and Patient Advocacy, Oncology with Sanofi, Elizabeth Franklin, PhD, MSW
23 Apr 2025
Contributed by Lukas
Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Elizabeth Franklin, PhD, MSW, Head of U.S. Public Affairs and Patient...
Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen
26 Mar 2025
Contributed by Lukas
Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Kirsten Axelsen, Senior Policy Advisor at DLA Piper & Non-Resident Fe...
Managing Director of Pharmagellan and Professor of the Practice at Tufts University, Frank S. David, MD, PhD
26 Feb 2025
Contributed by Lukas
Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Frank S. David, MD, PhD, Managing Director of Pharmagellan and Profes...
Author of the Cost Curve & the Principal and Founder of Reid Strategic, Brian Reid
29 Jan 2025
Contributed by Lukas
Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics interviews Brian Reid, Author of the Cost Curve & the Principal and Founder...
Welcome to Perspectives by the Leerink Center for Pharmacoeconomics
06 Jan 2025
Contributed by Lukas
In our signature podcast series, Dr. Mel Whittington, a health economist and Head of the Leerink Center for Pharmacoeconomics, talks with people from...